Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial - Bergenstal, R M; Wysham, C; Macconell, L (Lancet, 2010)
et al.